Skip to main content
Log in

Menaquinone-7 production in engineered Escherichia coli

  • Original Paper
  • Published:
World Journal of Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Menaquinone-7 (MK-7), a highly valuable member of the vitamin K2 series, is an essential nutrient for humans. In this study, to develop engineered Escherichia coli strains for MK-7 production, heterogeneous heptaprenyl pyrophosphate synthetase (HepPPS) was introduced, and MK-7 production was first achieved in engineered E. coli by overexpression of Bacillus subtilis-derived HepPPS (BsHepPPS). Then, by optimizing the enzyme expression of the heterogenous mevalonic acid (MVA) pathway and the BsHepPPS, the titre of MK-7 increased to 2.3 μM, which was 22-fold higher than that of the original strain. The competitive pathways of MK-7 were further investigated by deletion of ubiCA or ispB. Finally, the scale-up fermentation of the engineered E. coli in a 5-L fermenter was studied under aerobic conditions using glucose, and 13.6 μM (8.8 mg/L) MK-7 was achieved. Additionally, metabolite analysis revealed a new bottleneck in the MK-7 pathway at ubiE, suggesting an avenue for further optimization. This report is the first to describe the metabolic engineering of MK-7 in E. coli, which provides a new perspective for MK-7 production.

Graphic abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article [and its supplementary information files]. The authors agree that any materials newly described in the study are available to members of the scientific community for noncommercial purposes, if necessary, via an appropriate Materials Transfer Agreement between the interested parties.

References

Download references

Acknowledgements

This study was funded by the National Key Research and Development Project of China (2018YFA0901400) and the National Natural Science Foundation of China Grant (31670051).

Funding

This study was funded by the National Key Research and Development Project of China (2018YFA0901400) and the National Natural Science Foundation of China Grant (31670051).

Author information

Authors and Affiliations

Authors

Contributions

QG carried out the main work, collected and analysed the data, and drafted the manuscript. HC, WW and BL participated in the research. BL supervised the work and participated in data analysis and revised the manuscript. YT and JH participated in the conception and finalized the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jianzhong Huang or Baixue Lin.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Informed consent

Informed consent was obtained from all individual participants included in the study. Informed consent was obtained from all the authors included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 1200 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, Q., Chen, H., Wang, W. et al. Menaquinone-7 production in engineered Escherichia coli. World J Microbiol Biotechnol 36, 132 (2020). https://doi.org/10.1007/s11274-020-02880-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11274-020-02880-9

Keywords

Navigation